BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23846438)

  • 1. Prognostic and putative predictive biomarkers of gastric cancer for personalized medicine.
    Warneke VS; Behrens HM; Haag J; Balschun K; Böger C; Becker T; Ebert MP; Lordick F; Röcken C
    Diagn Mol Pathol; 2013 Sep; 22(3):127-37. PubMed ID: 23846438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtraction of Epstein-Barr virus and microsatellite instability genotypes from the Lauren histotypes: Combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases.
    Huang SC; Ng KF; Yeh TS; Cheng CT; Lin JS; Liu YJ; Chuang HC; Chen TC
    Int J Cancer; 2019 Dec; 145(12):3218-3230. PubMed ID: 30771224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
    Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U
    J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells.
    Oue N; Sentani K; Sakamoto N; Uraoka N; Yasui W
    Int J Clin Oncol; 2019 Jul; 24(7):771-778. PubMed ID: 30980196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status.
    Polom K; Das K; Marrelli D; Roviello G; Pascale V; Voglino C; Rho H; Tan P; Roviello F
    Pathol Oncol Res; 2019 Jan; 25(1):333-340. PubMed ID: 29116623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PARP1: A potential biomarker for gastric cancer.
    Afzal H; Yousaf S; Rahman F; Ahmed MW; Akram Z; Akhtar Kayani M; Mahjabeen I
    Pathol Res Pract; 2019 Aug; 215(8):152472. PubMed ID: 31174925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations.
    Wu MS; Shun CT; Wu CC; Hsu TY; Lin MT; Chang MC; Wang HP; Lin JT
    Gastroenterology; 2000 Jun; 118(6):1031-8. PubMed ID: 10833477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin and beta-catenin expression in Epstein-Barr virus-associated gastric carcinoma and their prognostic significance.
    Koriyama C; Akiba S; Itoh T; Sueyoshi K; Minakami Y; Corvalan A; Yonezawa S; Eizuru Y
    World J Gastroenterol; 2007 Aug; 13(29):3925-31. PubMed ID: 17663505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background.
    Tajima Y; Yamazaki K; Makino R; Nishino N; Aoki S; Kato M; Morohara K; Kaetsu T; Kusano M
    Clin Cancer Res; 2006 Nov; 12(21):6469-79. PubMed ID: 17085661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions.
    Tajima Y; Shimoda T; Nakanishi Y; Yokoyama N; Tanaka T; Shimizu K; Saito T; Kawamura M; Kusano M; Kumagai K
    Oncology; 2001; 61(3):212-20. PubMed ID: 11574777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinicopathological and molecular analysis of gastric cancer with altered SMARCA4 expression.
    Huang SC; Ng KF; Yeh TS; Cheng CT; Chen MC; Chao YC; Chuang HC; Liu YJ; Chen TC
    Histopathology; 2020 Aug; 77(2):250-261. PubMed ID: 32343857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 immunostaining cannot be used to predict TP53 mutations in gastric cancer: results from a large Central European cohort.
    Schoop I; Maleki SS; Behrens HM; Krüger S; Haag J; Röcken C
    Hum Pathol; 2020 Nov; 105():53-66. PubMed ID: 32971129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Clinicopathological Characteristics and Genetic Alterations Between Patients with Gastric Cancer with or Without
    Fang WL; Huang KH; Chang SC; Lin CH; Chen MH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM
    Oncologist; 2019 Sep; 24(9):e845-e853. PubMed ID: 30796154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic Characteristics of Microsatellite Instable Gastric Carcinomas Revisited: Urgent Need for Standardization.
    Mathiak M; Warneke VS; Behrens HM; Haag J; Böger C; Krüger S; Röcken C
    Appl Immunohistochem Mol Morphol; 2017 Jan; 25(1):12-24. PubMed ID: 26371427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm.
    Park CK; Park JS; Kim HS; Rha SY; Hyung WJ; Cheong JH; Noh SH; Lee SK; Lee YC; Huh YM; Kim H
    Oncotarget; 2016 Nov; 7(44):72099-72112. PubMed ID: 27765925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine.
    Kumagai R; Kohashi K; Takahashi S; Yamamoto H; Hirahashi M; Taguchi K; Nishiyama K; Oda Y
    World J Gastroenterol; 2015 Mar; 21(9):2700-10. PubMed ID: 25759539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas.
    Baldus SE; Zirbes TK; Engel S; Hanisch FG; Mönig SP; Lorenzen J; Glossmann J; Fromm S; Thiele J; Pichlmaier H; Dienes HP
    Int J Cancer; 1998 Apr; 79(2):133-8. PubMed ID: 9583726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte-rich gastric cancer: associations with Epstein-Barr virus, microsatellite instability, histology, and survival.
    Grogg KL; Lohse CM; Pankratz VS; Halling KC; Smyrk TC
    Mod Pathol; 2003 Jul; 16(7):641-51. PubMed ID: 12861059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are Immunohistochemical Markers Useful in Phenotypic Gastric Cancer Classification?
    Di Pinto F; Armentano R; Arborea G; Schena N; Donghia R; Valentini AM
    Oncology; 2020; 98(8):566-574. PubMed ID: 32316005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic and Immunohistochemical Characteristics of Gastric Cancer with versus without Helicobacter Pylori Eradication.
    Kodama M; Okimoto T; Mizukami K; Abe H; Ogawa R; Okamoto K; Shuto M; Matsunari O; Hirashita Y; Sato R; Abe T; Nagai T; Arita T; Murakami K
    Digestion; 2018; 97(4):288-297. PubMed ID: 29514141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.